Displaying 111 - 120 of 1657
Consumers First submitted comments to the Center for Medicare and Medicaid Services on the CY 2024 Medicare Outpatient Prospective Payment System proposed rule, which sets the payment rates for how most hospitals are paid…
More than 60 organizations representing consumers, patients, employers, and other health care stakeholders submitted a letter to Congressional Leadership urging Congress to advance and enact legislation that strengthens and codifies price transparency regulations and…
On Wednesday, September 6, Senator Peter Welch (D-Vt.) joined Families USA and Patients for Affordable Drugs Now for a virtual press conference to break down and discuss the future impact and implications for the…
The stage is officially set and the Center for Medicaid and Medicare Services (CMS) has officially begun to negotiate drug prices in Medicare for the first time. Almost a quarter of people over 65…
Americans are struggling with an affordability crisis and rising health care costs, yet our health care system is full of wasteful spending that does not improve people’s health. One prime example of this is…
People should know the price of health care services at a hospital or health care facility before they receive care, whether it is an X-ray, an MRI or a surgery. Yet, health care is…
It has been exactly one year since the Inflation Reduction Act was signed into law, putting significant drug pricing reforms into effect that both expand access to medication and make it more affordable for…
Addressing high and rising drug costs across the country is a key to ensuring high-quality, affordable health care and improved health for all. And it is an issue affecting millions of families regardless of…
Families USA Action joined the Leukemia and Lymphoma Society and 14 additional consumer and patient organizations in signing this amicus brief defending the No Surprises Act (NSA) in litigation filed by New York surgeon…
For the first time in history, thanks to prescription drug price reforms in the Inflation Reduction Act, the federal government can negotiate directly with big drug companies to lower the outrageous prices they are…